EMPE is going for clinical evaluation

With immense of optimism and confidence, we have agreed to perform a multi-national clinical evaluation for the assessment of our first product, the mfloDx® MDR-TB test. The product will be validated in at least seven WHO sponsored Supernational Reference Laboratories in Europe and Asia. The clinical evaluation is scheduled to start in Jan. 2018.